Literature DB >> 18383177

Guttate psoriasis induced by infliximab in a child with Crohn's disease.

Marta Costa-Romero, Pablo Coto-Segura, Sonsoles Suarez-Saavedra, Eduardo Ramos-Polo, Jorge Santos-Juanes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18383177     DOI： 10.1002/ibd.20450

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN： 1078-0998            Impact factor:   5.325


× No keyword cloud information.
  5 in total

Review 1.  Paradoxical inflammation induced by anti-TNF agents in patients with IBD.

Authors:  Isabelle Cleynen; Séverine Vermeire
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-07-03       Impact factor: 46.802

2.  Rash induced by anti-tumor necrosis factor agents in an adolescent with Crohn's disease.

Authors:  Laurie S Conklin; Bernard Cohen; Lindsay Wilson; Carmen Cuffari; Maria Oliva-Hemker
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-03       Impact factor: 46.802

3.  Multitarget fatty acid amide hydrolase/cyclooxygenase blockade suppresses intestinal inflammation and protects against nonsteroidal anti-inflammatory drug-dependent gastrointestinal damage.

Authors:  Oscar Sasso; Marco Migliore; Damien Habrant; Andrea Armirotti; Clara Albani; Maria Summa; Guillermo Moreno-Sanz; Rita Scarpelli; Daniele Piomelli
Journal:  FASEB J       Date:  2015-03-10       Impact factor: 5.191

4.  Psoriasis Associated With Tumor Necrosis Factor Inhibitors in Children With Inflammatory Diseases.

Authors:  Lisa H Buckley; Rui Xiao; Marissa J Perman; Andrew B Grossman; Pamela F Weiss
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-01-03       Impact factor: 4.794

5.  Paradoxical Psoriasis Induced by Anti-TNFα Treatment: Evaluation of Disease-Specific Clinical and Genetic Markers.

Authors:  Agostino Bucalo; Federica Rega; Arianna Zangrilli; Valentina Silvestri; Virginia Valentini; Giorgia Scafetta; Federica Marraffa; Sara Grassi; Elena Rogante; Arianna Piccolo; Salvatore Cucchiara; Franca Viola; Luca Bianchi; Laura Ottini; Antonio Richetta
Journal:  Int J Mol Sci       Date:  2020-10-23       Impact factor: 5.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.